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Background: Isolated, nonsyndromic cleft lip with or without cleft palate is a common human
congenital malformation with a complex and heterogeneous etiology. Genes coding for
fibroblast growth factors and their receptors (FGF/FGFR genes) are excellent candidate genes.
Methods:We tested single-nucleotide polymorphic markers in 10 FGF/FGFR genes (including
FGFBP1, FGF2, FGF10, FGF18, FGFR1, FGFR2, FGF19, FGF4, FGF3, and FGF9) for genotypic
effects, interactions with one another, and with common maternal environmental exposures in
221 Asian and 76 Maryland case-parent trios ascertained through a child with isolated,
nonsyndromic cleft lip with or without cleft palate.
Results: Both FGFR1 and FGF19 yielded evidence of linkage and association in the transmission
disequilibrium test, confirming previous evidence. Haplotypes of three single-nucleotide polymor-
phisms in FGFR1were nominally significant among Asian trios. Estimated odds ratios for individual
single-nucleotide polymorphic markers and haplotypes of multiple markers in FGF19 ranged from
1.31 to 1.87. We also found suggestive evidence of maternal genotypic effects for markers in FGF2
and FGF10 among Asian trios. Tests for gene-environment (G 3 E) interaction between markers in
FGFR2 andmaternal smoking ormultivitamin supplementation yielded significant evidence of G3E
interaction separately. Tests of gene-gene (G 3 G) interaction using Cordell’s method yielded
significant evidence between single-nucleotide polymorphisms in FGF9 and FGF18, which was
confirmed in an independent sample of trios from an international consortium.
Conclusion: Our results suggest several genes in the FGF/FGFR family may influence risk for
isolated, nonsyndromic cleft lip with or without cleft palate through distinct biological
mechanisms.
KEY WORDS: FGF/FGFR, maternal effects, gene-environment interaction, gene-gene interaction,
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Isolated, nonsyndromic cleft lip with or without cleft
palate (iCL6P) represents one of the most common human
birth defects (Mossey and Little, 2002) and has a complex
and heterogeneous etiology that remains poorly understood
(Jugessur and Murray, 2005). There is a strong genetic
component to the etiology of this common birth defect. A
multifactorial threshold model of inheritance reflecting
multiple distinct causal genes is often assumed (Grosen
et al., 2010). Genome-wide linkage screens in multiplex
families have shown that multiple regions of the genome
may harbor causal genes with a high degree of linkage
heterogeneity (Marazita et al., 2004; Marazita et al., 2009).
Recently, genome-wide association studies (GWAS) have
identified a region on chromosome 8q24 as strongly asso-
ciated with risk for iCL6P; although, it is relatively devoid
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of genes, raising the possibility that noncoding genetic
regions are also critical (Birnbaum et al., 2009; Grant et al.,
2009; Beaty et al., 2010). Several studies have also shown
suggestive evidence for interaction between candidate genes
and environmental risk factors, especially maternal smok-
ing (Zeiger et al., 2005; Shi et al., 2007a) and nutrient intake
(Shaw et al., 1998) in controlling risk for iCL6P; although,
the evidence for gene-environment (G 3 E) interaction
remains difficult to confirm. Therefore, genes and regula-
tory elements outside of coding regions, plus their possible
interactions with each other (G 3 G interaction) and with
environmental factors, should be considered when search-
ing for potential causal genes for iCL6P.
Genes in the fibroblast growth factor (FGF) signaling
pathway are excellent candidate genes for iCL6P (Nie
et al., 2006; Riley et al., 2007a; Riley et al., 2007b; Riley
et al., 2007c; Menezes et al., 2008). Here we tested markers
in 10 FGF and FGF receptor (FGFR) genes for their poten-
tial role in controlling risk to iCL6P using 297 case-parent
trios from four populations.
MATERIALS AND METHODS
Sample Description
As part of an international study, we collected peripheral
blood, environmental exposures, and other data on iCL6P
case-parent trios recruited through treatment centers at
Johns Hopkins and University of Maryland in Maryland
(MD), Chang Gung Memorial Hospital in Taiwan (TW),
KK Women’s and Children’s Hospital in Singapore (SP),
and Yonsei Medical Center in South Korea (KR). History
of maternal exposure to cigarette smoking, alcohol con-
sumption, and vitamin supplementation was collected from
a personal interview of mothers that covered the peri-
conceptual period (3 months before conception through the
first trimester). All probands underwent clinical genetic
evaluation (including checking for other congenital anom-
alies or major developmental delays) and were classified as
having an isolated, nonsyndromic iCL6P. Research pro-
tocols were reviewed and approved by institutional review
boards at each participating institution.
Single-Nucleotide Polymorphism Selection, DNA,
and Genotyping
Single-nucleotide polymorphisms (SNPs) were selected in
10 FGF/FGFR genes (including FGFBP1, FGF2, FGF10,
FGF18, FGFR1, FGFR2, FGF19, FGF4, FGF3, and FGF9)
with a goal of identifying one SNP per 5 kilobase pairs (kb)
of physical distance. Because Hapmap data were not fully
available at the time our SNPs were chosen, we could not
identify all possible tagging SNPs. Variants with ‘‘SNP
scores’’ .0.6 (an assessment of design quality of the
Illumina assay based on a proprietary algorithm), high
validation levels in the SNP database (dbSNP) (including
validation on multiple platforms), and high heterozygosity
levels (particularly in multiple populations) were given
priority. The SNP markers were genotyped using Illumina’s
GoldenGate chemistry (Oliphant et al., 2002) at the Genetic
Resources Core Facility (GRCF) at Johns Hopkins. Two
duplicates and four controls from the Centre d’Etude du
Polymorphisme Humain collection were included on each
plate to evaluate genotyping consistency within and
between plates.
Statistical Analysis
Genotyping rate, minor allele frequency (MAF), pairwise
linkage disequilibrium (LD), and Hardy-Weinberg equilib-
rium (HWE) were evaluated within each population and in
three Asian populations combined. The LD was measured
as r2 for all SNPs using Haploview (Barrett et al., 2005).
The SNPs were tested when the following criteria were
satisfied: MAF.1%, compatibility with HWE at p. .01 in
each group, and overall genotyping rate.80%. None of the
SNPs between different FGF/FGFR genes on the same
chromosome were in LD (data not shown), so the 10 FGF/
FGFR genes were analyzed separately.
Statistical significance of transmission distortion from
parents to the affected offspring was evaluated using the
family-based association test (http://www.biostat.harvard.
edu/,fbat/fbat.htm) for each individual SNP and for
haplotypes of multiple SNPs (Laird and Lange, 2006).
Numbers of transmitted and nontransmitted alleles for
both single SNPs and haplotypes were generated using
PLINK v1.07 (http://pngu.mgh.harvard.edu/purcell/plink/,
Purcell et al., 2007). The 95% confidence interval for
estimated odds ratios (ORs) of overtransmission were
calculated by a binomial exact test in STATA (v. 10.0,
StataCorp, 2007).
Analysis of maternally mediated in utero effects was
performed using the TRIad Multi-Marker (TRIMM)
package under an assumption of mating symmetry in the
population (Shi et al., 2007b). Paired difference counts (D)
of the number of target alleles carried by father and mother
is a key component in constructing standardized normal
(Z) statistics for the mean D across all markers, and the
maximum Z2 (max_Z2) served as a test statistic. Empiric
significance of maternal genotypic effects was evaluated by
permuting these max_Z2 values over random reassignments
of ‘‘father’’ and ‘‘mother.’’ To optimize power, max_Z2 and
Hotelling T2 tests were used to generate a combined p value
(sum_logP) from these two tests. If the global max_Z2 test
gave a p , 0.1, the apparent risk allele or haplotype was
used in the log-linear framework originally proposed by
Weinberg et al. (1998) to estimate relative risks. Odds ratios
and their significance associated with the mother’s carrying
one copy (S1) of the risk allele/haplotype was assessed by a
likelihood ratio test (LRT) under the log-additive model
(where ORs associated with carrying two copies is simply
S1
2) as implemented in the Triad Multi-Marker relative risk
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estimation program (TRIMMEST) (http://www.niehs.nih.
gov/research/atniehs/labs/bb/staff/weinberg; Shi et al., 2009).
A general model was used to estimate the OR for FGF2,
where four haplotypes were present, but a more restricted
model assuming HWE was used for FGF10 where 11 haplo-
types were observed (because the more general model would
have required too many parameters).
Family-based association tests for individual SNPs or two-
to three-SNP sliding window haplotypes incorporating aG3
E interaction term with maternal smoking and vitamin
supplementation were performed in a combined 2 degrees of
freedom (df) score test for main effects of genotype (G) andG
3E interaction together, followed by a 1 df score test for G3
E interaction alone using PBAT (v3.6; http://www.biostat.
harvard.edu/,clange/default.htm).
We used Cordell’s (2002) LRT for possible G 3 G
interaction assessment among markers in these 10 FGF/
FGFR genes. Using a conditional logistic regression model,
the observed two-locus genotype of the case was compared
with the 15 possible ‘‘pseudo-sib’’ control genotypes, gene-
rating a 4 df test. To address the issue of multiple com-
parisons, we carried out permutation tests where case
versus pseudo-sib control status was randomly shuffled
1000 times for each trio to generate new sets of data under
the null hypothesis. An empirical p value for the most
significant SNP was determined by comparing the observed
test statistic with these 1000 replicates.
Although markers in these 10 FGF/FGFR genes were
typed as part of a candidate gene study conducted before
the international consortium described by Beaty et al.
(2010), 157 of these 297 (52.9%) case-parent trios went into
that genome-wide study. In a confirmatory analysis of G 3
G interaction, we removed these overlapping trios from the
international consortium data set and used all remaining
case-parent trios (n 5 1434), which represents an indepen-
dent replication sample of iCL6P case-parent trios.
RESULTS
A total of 297 trios were collected from four populations
(MD, TW, SP, and KR), and Table 1 lists gender and race
of all iCL6P probands. Among the 122 SNPs genotyped in
these 10 FGF/FGFR genes, nine SNPs were dropped due to
low MAF and another two SNPs were dropped due to low
genotyping call rate. Genotype distributions for the remain-
ing 111 SNPs were all compatible with HWE (data not
shown).
When analyzing transmission distortion of individual
SNPs among these 10 FGF/FGFR genes, two independent
markers in FGF19 showed nominally significant evidence of
linkage and association (p , .05) with iCL6P among Asian
trios, and another SNP was significant only among MD trios
(Table 2). Estimated ORs for carrying the apparent high-risk
allele at each of these three FGF19 SNPs ranged from 1.37 to
1.87. Analysis of sliding window haplotypes using two to five
SNPs together confirmed the significance of markers in
FGF19 among Asian trios, and a three-SNP haplotype in
FGFR1 (rs6987534, rs6474354, and rs10958700) gave p 5 .04
(corrected p 5 .30) among Asian trios.
In testing for possible maternal genotype effects, one
four-SNP haplotype in FGF2 and another six-SNP
haplotype in FGF10 showed significant empiric evidence
of an increased risk of iCL6P in offspring that depended
solely upon maternal genotype among Asian trios. The
corresponding ORs for the child being affected were
estimated as 1.72 (x2 5 11.47, empiric p 5 .0007) and
1.61 (x2 5 7.29, empiric p 5 .0069) if the mother carried
one copy of the risk haplotype (Table 3).
Although the rate of maternal alcohol consumption was
too low to permit separate analysis, about 5% and 25%
Asian mothers reported smoking and taking vitamin
supplements, respectively, during the critical peri-concep-
tional period (Sull et al., 2009). Significant evidence of G 3
E interaction was seen among Asian populations for
FGFR2 (Fig. 1). For G 3 Smoking analysis, the most
significant evidence was seen in a two-SNP haplotype
(rs2981428 and rs3750817) that yielded a p5 .0058 in a 1 df
test (Fig. 1) that was not significant after strict Bonferroni
correction. For G 3 Vitamin interaction, the strongest
evidence in FGFR2 was seen both in 1 df test for a single
SNP (rs2912771; p 5 .00027, corrected p 5 .042) and in the
2 df test for a three-SNP haplotype (involving rs4752566,
rs2912760, and rs3135761; p 5 .00021, corrected p 5 .033).
These p values for G 3 Vitamin interaction remained
significant after strict Bonferroni correction for all 156 tests
conducted on the 27 markers and their haplotypes in
FGFR2. As seen in the lower panel of Figure 1, several
other SNPs and haplotypes also showed nominal signifi-
cance in either the 1 df or the 2 df test for G 3 Vitamin
interaction.
A total of 16 pairs of SNPs in different FGF genes
attained nominal significance in tests of G 3 G interaction
(Table 4). The most significant LRT was generated by
rs2043278 in FGF18 and rs12870202 in FGF9 (p 5 .0001),
TABLE 1 Gender and Racial Origin of 297 Cleft Lip With or Without Cleft Palate Probands From Four Populations
Racial Origin
Maryland Taiwan Singapore Korea Total
Male Female Male Female Male Female Male Female Male Female
European 41 29 0 0 1 1 0 0 42 30
African 3 3 0 0 0 0 0 0 3 3
Asian 0 0 95 51 23 10 22 18 140 79
Total 44 32 95 51 24 11 22 18 185 112
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which remained significant (p 5 .019) after correcting for
multiple comparisons via permutation tests. Only 1.9% of
replicates (across the 338 separate tests for G 3 G
interactions) generated under the null hypothesis exceeded
this observed test statistic (Table 4; Fig. 2).
To follow up on the intriguing evidence for G 3 G
interaction between FGF9 and FGF18 seen here, an
independent replication sample of 1434 case-parent trios
was examined in a confirmatory test of G 3 G interaction
using markers in these two genes. Only rs2043278 in FGF18
was included in the genome-wide marker panel, but 11
different SNPs in or near FGF9 gave a nominally signi-
ficant evidence of G 3 G interaction with this one SNP
(Table 5). When all 38 SNPs in FGF18 were examined with
the 140 SNPs mapping to FGF9, several additional pairs
of SNPs in these two genes showed further evidence
of possible G 3 G interaction (see Fig. 3). The most
significant pairs involved SNPs located in the intergenic
region 39 of the gene; some are as far as 500 kb away.
DISCUSSION
In our analysis of 111 markers in 10 FGF/FGFR genes
using 297 case-parent trios collected from an international
study, SNPs in seven of these genes gave some evidence of
linkage and association with unobserved causal variants
for iCL6P. Genes in the FGF/FGFR pathway are
considered good candidates for iCL6P because they play
important roles in craniofacial development (Kurose et al.,
2004; Rice et al., 2004; Jugessur et al., 2009) and several of
them (FGFR1, FGFR2, and FGF10) control Mendelian
malformation syndromes that can include oral clefts as a
TABLE 2 SNPs Yielding Significant or Marginally Significant Associations From Analysis of 111 Markers in 10 FGF/FGFR Genes From Family-
Based Association Tests for Single SNPs and Two- to Five-SNP Haplotypes in Analysis of 76 Maryland Trios and 221 Asian Trios Separately*
Site Gene SNP Name
Risk Allele/
Haplotype Percentage
Informative
Families (n) T NT OR (95% CI) p Value
Single-SNP analysis
Asian FGF19 rs3737463 1 66.6 148 112 78 1.44 (1.07–1.94) 0.0136
Asian FGF19 rs948992 2 55.4 148 114 83 1.37 (1.03–1.85) 0.0272
MD FGF19 rs1789364 2 38.9 33 28 15 1.87 (0.96–3.76) 0.0474
MD FGF2 rs308395 1 18.8 18 14 5 2.80 (0.95–9.93) 0.0640
Haplotype analysis
Asian FGFR1 rs6987534 2,2,1 12.4 79 28 55 0.51 (0.31–0.82) 0.0411
rs6474354
rs10958700
Asian FGF19 rs3737463 1,2 45.1 145 117 82 1.43 (1.07–1.92) 0.0271
rs948992
Asian FGF19 rs3737463 1,2,1 45.1 142 119 82 1.45 (1.09–1.95) 0.0161
rs948992
rs1307968
Asian FGF19 rs3737463 1,2,1,1 45.3 142 116 80 1.45 (1.08–1.95) 0.0272
rs948992
rs1307968
rs1320706
Asian FGF19 rs3737463 1,2,1,1,1 36.2 126 101 77 1.31 (0.97–1.79) 0.0498
rs948992
rs1307968
rs1320706
rs1789364
* T 5 number of transmitted risk alleles or risk haplotypes; NT 5 number of not transmitted risk alleles or risk haplotypes; OR 5 odds ratio; 95% CI 5 95% confidence interval.
TABLE 3 Maternal Risk Haplotypes Identified by TRIMM From Analysis of 28 Markers in the FGF2 and FGF10 Genes Under an Additive Model
Where Maternal Genotype Alone (S1) Controls Risk for Cleft Lip With or Without Cleft Palate in Offspring From TRIMMEST Analysis in 221 Asian Trios*
Gene (No. Chr) No. of SNPs Sum_logP SNPs Risk Allele
Estimated
Risk for Mat.
Hap. S1
Risk Hap. Freq
x2 p0 1 2
FGF2(4) 12 0.024 rs3789138 1 1.72 0.22 0.52 0.26 11.47 .0007
rs308388 1
rs1476214 1
rs1476217 2
FGF10(5) 16 0.027 rs10057630 1 1.61 0.25 7.29 .0069
rs1448037 1
rs593307 1
rs339502 2
rs1384449 2
rs2973647 1
* Chr 5 chromosome; Estimated risk for Mat. Hap. S1 5 estimated risk for maternal haplotype S1; Risk Hap. Freq 5 risk haplotype frequencies.
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FIGURE 1 Testing for main effects (G) of individual SNPs (haplotypes) of FGFR2 and gene-environment interaction (G 3 E) for two common maternal
exposures in 221 CL±P case-parent trios from Asian populations. Triangles represent the 2 df test of G and G 3 E interaction; squares represent the 1 df test of
G 3 E only. Haplotypes of two- and three-SNPs are connected by solid lines for the 2 df test and dotted lines for the 1 df test (only nominally significant
haplotypes are shown here). rs2912762*: The distance between rs3135761 and rs2912762 were drawn for clarity (true distance between these two SNPs is 199
base pairs).
TABLE 4 Significant Tests for G 3 G interaction Among 111 Markers in 10 Different FGF/FGFR Genes in 297 Cleft Lip With or Without Cleft
Palate Case-Parent Trios From Four Populations Based on 4 df LRT Testing for Two-Way Interaction
First Gene Second Gene Marker 1 Marker 2
Test Statistic p Value
Gene Chromosome Gene Chromosome
SNP1 SNP2snp1 snp1 snp2 snp2
fgf18 5 fgf10 5 rs4559013 rs11750845 14.255 .0065
fgf18 5 fgf10 5 rs4076077 rs11750845 14.300 .0064
fgf18 5 fgf10 5 rs4076077 rs1482679 14.156 .0068
fgf18 5 fgf10 5 rs3934591 rs1482679 17.743 .0014
fgf18 5 fgfr1 8 rs6887323 rs2978073 13.604 .0087
fgf18 5 fgf3 11 rs6887323 rs1893047 15.135 .0044
fgf18 5 fgf3 11 rs2043278 rs11263592 14.199 .0067
fgf18 5 fgf3 11 rs2043278 rs1893047 13.958 .0074
fgf18 5 fgf9 13 rs2043278 rs12870202 23.854 .0001*
fgfr2 10 fgf10 5 rs2981430 rs593307 13.556 .0089
fgfr2 10 fgf10 5 rs2981430 rs339502 13.815 .0079
fgfr2 10 fgf10 5 rs2981430 rs1384449 14.338 .0063
fgfr2 10 fgfr1 8 rs2981427 rs4733930 15.973 .0031
fgf3 11 fgfbp1 4 rs11263592 rs732245 13.590 .0087
fgf3 11 fgfbp1 4 rs11263587 rs732245 13.563 .0088
fgf9 13 fgfr1 8 rs6490667 rs4733930 14.010 .0073
* Only this two-SNP interaction remained significant after 1000 permutations with a p value of .019.
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hallmark feature (Slaney et al., 1996; Dode´ et al., 2003;
Entesarian et al., 2005). Genes can contribute to the
etiology of nonsyndromic forms of oral clefts as well as
Mendelian malformation syndromes, such as interferon
regulatory factor 6 (Kondo et al., 2002; Zucchero et al.,
2004).
Fine-mapping linkage scans in the 8p11-23 chro-
mosomal region (Riley et al., 2007c), association, and
sequencing studies (Riley et al., 2007a; Riley et al., 2007b)
offered further support for FGFR1 as a good candidate
for iCL6P. Our analysis of markers in FGFR1 gene
confirmed these previous reports. However, neither
results from our or Riley’s studies would retain statistical
significance if strict Bonferroni correction for multiple
testing were used. Although there is no previous evidence
that FGF19 influences risk for iCL6P, our results
combined with evidence from animal models (Kurose
et al., 2004) suggest further investigation of this gene may
be warranted.
Mutations in noncoding regions of FGF2 and FGF10 can
result in impaired transcription (Riley et al., 2007b). Our
analysis showed intriguing evidence for maternal genotypic
effects controlling the offspring’s risk of iCL6P for
markers in these two genes among Asians, though fetal
effects identified in two previous studies for SNPs in FGF10
(Riley et al., 2007b; Menezes et al., 2008) were not con-
firmed here. Maternal genes control the in utero environ-
ment, so potential maternal genotype effects of markers in
FGF2 and FGF10 genes seen among our Asian trios may be
important (Boyles et al., 2009).
Sequence analysis identified several rare mutations in
coding regions of FGFR2, which may be causal (Riley et al.,
2007a; Riley et al., 2007b). In our study, SNPs in FGFR2
showed suggestive evidence of G 3 E interaction with
maternal smoking and significant evidence of interaction
with vitamin supplementation (even after Bonferroni
correction). Evidence from association studies with mark-
ers in FGFR2 across studies has been inconsistent (Riley
et al., 2007a; Menezes et al., 2008), but our suggestion of G
3 E interaction deserves further investigation given the
potential for public health intervention with modifiable
environmental risk factors.
Potentially important mutations in noncoding regions of
FGF9 were identified in a separate sequencing study (Riley
et al., 2007a; Riley et al., 2007b). Our analysis of 297 trios
FIGURE 2 Distribution of maximum LRT values over 1000 replicates.
Histograms represent the frequency of maximum test statistics generated
under the null hypothesis of no G 3 G interaction. The vertical line shows
the position of observed test statistic of G 3 G interaction between
rs12870202 and rs2043278. About 1.9% of permutated test statistics
exceeded this observed value, giving an empiric p value corrected for
multiple testing (p = .019).
TABLE 5 Tests for G 3 G interaction between rs2043278 in FGF18
and 11 SNPs in FGF9 that achieved nominal significance in 1434 case-
parent trios from the International Cleft Consortium
SNP Pair Position in FGF9 Statistic Nominal p
rs2043278 : rs829209 21133584 10.05 .0396
rs2043278 : rs9634328 21136546 10.71 .0300
rs2043278 : rs672905 21281253 9.42 .0514
rs2043278 : rs7999069 21284490 12.27 .0154
rs2043278 : rs17073403 21383899 9.61 .0475
rs2043278 : rs7338014 21384015 10.77 .0293
rs2043278 : rs9580272 21474452 13.59 .0087
rs2043278 : rs12853883 21529175 10.16 .0378
rs2043278 : rs725600 21643202 10.70 .0301
rs2043278 : rs9552612 21652578 11.60 .0205
rs2043278 : rs17326684 21667539 10.52 .0325
FIGURE 3 Significance [as 2log10(p)] from the 4 df LRT for Cordell’s
test of G 3 G interaction between markers in FGF18 and FGF9 plotted
against the physical position in FGF9. SNP (rs2043278) in FGF18 is an
intronic marker located at 170815212 (Build 36) and showed moderately
significant p values for 11 different SNPs in FGF9 (solid circles), most of
which were located in the 39UTR (some as far as 500 kb away from the
coding region of FGF9). Five additional SNPs in FGF18 also yielded strong
evidence of G 3 G interaction with SNPs in the intergenic region 39 of the
FGF9 coding region (open symbols).
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showed intriguing evidence for possible G 3 G interaction
between FGF18 and FGF9 that may be important for
iCL6P. Using independent trios from the International
Cleft Consortium described by Beaty et al. (2010), we
confirmed the significance of G 3 G interaction between
markers in FGF9 and FGF18 identified in these 297 trios,
although the strongest evidence was seen for markers distal
to the 39 end of FGF9 (well away from coding regions). The
combination of statistical evidence from these 297 trios and
from the 1434 independent trios from the GWAS makes it
more likely these findings are biologically meaningful. Very
few GWAS signals are actually found in coding sequences
(Hindorff et al., 2009), and the strongest association signal
for iCL6P in Europeans lies in an apparent ‘‘gene desert’’
on chromosome 8q24 (Birnbaum et al., 2009; Grant et al.,
2009; Beaty et al., 2010). Similar regulators may underlie
these associations, and one can imagine a shared enhancer
sequence could explain the suggested interaction between
these two FGF genes.
Our association results confirmed some previous find-
ings from published linkage, association, and sequencing
analysis for various FGF/FGFR genes and provided new
clues about how these different genes may act through
potential maternal genotypic effects and G 3 E and G 3 G
interactions to control risk of iCL6P. Although some of
the statistical evidence presented here did not retain
significance after strict Bonferroni correction, mechanisms
of G 3 G interaction in particular require further
investigation.
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